Study Information
| Title: | A Study of Trastuzumab-MCC-DM1, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer  |
| Status: | Recruiting participants |
| Conditions: | Metastatic Breast Cancer |
| Interventions: | Drug: paclitaxel; Drug: pertuzumab; Drug: trastuzumab-MCC-DM1 |
| Institutions: | Dana-Farber Cancer Institute |
| Health Topics: | Breast Cancer |
Contact Information
Dana Farber Cancer Institute
Boston, MA 02115
Kathryn Josephs
617-582-7652
KathrynE_Josephs@DFCI.Harvard.edu